20160128 EGA Regulatory and Scientific Affairs Conferenc

Joint EU-UK pharmaceutical industry response to Specialised Committee outcome

9 November 2020


Am fost foarte mândru de eforturile industriei noastre de a uni și a pune interesul pacienților absolut pe primul loc în timpul acestei crize

5 October 2020

Interviu cu Adrian van den Hoven, director general Medicines for Europe  […]

Read more

IGBA: Global Roadmap for Tailored Clinical Biosimilar Development: Instrumental for Sustainable Access to Biologics

24 September 2020


Joint press statement of European Pharmaceutical industry associations

17 September 2020


Decisive action on medicines shortages should be included in pharmaceutical and industrial strategies

17 September 2020


Practical measures are paramount for robust medicines manufacturing

9 September 2020


Interview: Medicines for Europe Reports on EU Biosimilar Success

27 July 2020

The Center for Biosimilars® (CfB) spoke with Adrian van den Hoven, […]

Read more

Christoph Stoller and Adrian van den Hoven interviewed by PharmaBoardroom

17 July 2020

In the wake of the publication of Medicines for Europe’s Lessons […]

Read more

Resolving and mitigating medicine shortages in the EU

10 February 2020

Drug shortages can greatly impact patients and the pharmaceutical industry. […]

Read more

Arun Narayan – Chairman, Value Added Medicines Group, Medicines for Europe

31 January 2020

Arun Narayan is the Chairman of the Value Added Medicines […]

Read more

Subscribe to our newsletter